益安生醫股份有限公司
益安生醫股份有限公司（Medeon Biodesign, Inc.）為微創手術器材之研發與授權商。核心業務為開發具備高門檻技術的二類或三類醫療器材，如大口徑血管縫合器（Cross-Seal）、前列腺肥大手術器械及骨科微創耗材。公司採取「研發、臨床試驗後進行國際大廠授權」的經營模式。公司成立於 2012 年，總部位於台灣台北市。
該股 RSI(6) 為 51.3，處於中性區間，短線無明顯超買超賣訊號。股價站上20日、60日均線，跌破5日、120日均線。短中期均線呈多頭排列，趨勢偏多。KD 指標中性（K=46.9）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | +8 | 0 | 0 | +8 |
| 09-23 | +2 | 0 | 0 | +2 |
| 09-22 | -86 | 0 | 0 | -86 |
| 09-21 | -158 | 0 | +6 | -158 |
| 09-18 | -22 | 0 | 0 | -22 |
| 09-17 | -8 | 0 | 0 | -8 |
| 09-16 | +45 | 0 | +2 | +45 |
| 09-15 | +13 | 0 | +2 | +14 |
| 09-14 | +22 | 0 | +8 | +22 |
| 09-11 | -59 | 0 | +2 | -59 |
| 09-10 | +71 | 0 | 0 | +71 |
| 09-09 | -7 | 0 | +4 | -7 |
| 09-08 | +7 | 0 | 0 | +7 |
| 09-07 | -11 | 0 | 0 | -11 |
| 09-04 | -20 | 0 | 0 | -20 |
| 09-03 | -127 | 0 | +4 | -127 |
| 09-02 | +89 | 0 | +2 | +89 |
| 09-01 | -202 | 0 | +2 | -203 |
| 08-31 | -327 | 0 | +2 | -327 |
| 08-28 | +201 | 0 | +2 | +202 |
| 08-27 | -306 | 0 | +4 | -306 |
| 08-26 | +123 | 0 | +6 | +124 |
| 08-25 | +22 | 0 | 0 | +22 |
| 08-24 | -8 | 0 | 0 | -8 |
| 08-21 | -178 | 0 | +2 | -179 |
| 08-20 | +45 | 0 | +3 | +46 |
| 08-19 | -20 | 0 | 0 | -21 |
| 08-18 | +42 | 0 | +2 | +43 |
| 08-17 | -340 | 0 | +4 | -340 |
| 08-14 | -51 | 0 | 0 | -51 |
| 08-13 | -36 | 0 | +2 | -35 |
| 08-12 | +12 | 0 | 0 | +11 |
| 08-11 | +56 | 0 | 0 | +56 |
| 08-10 | +129 | 0 | 0 | +129 |
| 08-07 | +1 | 0 | +4 | +1 |
| 08-06 | -30 | 0 | +2 | -30 |
| 08-05 | -58 | 0 | 0 | -58 |
| 08-04 | +134 | 0 | 0 | +134 |
| 08-03 | +10 | 0 | +2 | +10 |
| 07-31 | +3 | 0 | 0 | +3 |
| 07-30 | +95 | 0 | +4 | +96 |
| 07-29 | +335 | 0 | +2 | +334 |
| 07-28 | +61 | 0 | +2 | +62 |
| 07-27 | +37 | 0 | +2 | +37 |
| 07-24 | +12 | 0 | 0 | +12 |
| 07-23 | -6 | 0 | +2 | -6 |
| 07-22 | -18 | 0 | +2 | -18 |
| 07-21 | -23 | 0 | 0 | -23 |
| 07-20 | +216 | 0 | 0 | +216 |
| 07-17 | +2 | 0 | 0 | +2 |
| 07-16 | -10 | 0 | 0 | -10 |
| 07-15 | -9 | 0 | 0 | -9 |
| 07-14 | +46 | 0 | +14 | +47 |
| 07-13 | +9 | 0 | +2 | +9 |
| 07-09 | +25 | 0 | 0 | +25 |
| 07-08 | -72 | 0 | +4 | -73 |
| 07-07 | +62 | 0 | +2 | +62 |
| 07-06 | +30 | 0 | +2 | +30 |
| 07-03 | +15 | 0 | +2 | +15 |
| 07-02 | -19 | 0 | 0 | -19 |
| 07-01 | +10 | 0 | +4 | +10 |
| 06-30 | -40 | 0 | +4 | -40 |
| 06-29 | -12 | 0 | +14 | -13 |
| 06-26 | -79 | 0 | +13 | -79 |
| 06-25 | -27 | 0 | +6 | -28 |
| 06-24 | +4 | 0 | 0 | +4 |
| 06-23 | +46 | 0 | +1 | +46 |
| 06-22 | -33 | 0 | +6 | -33 |
| 06-18 | +44 | 0 | +2 | +44 |
| 06-17 | -118 | 0 | +7 | -117 |
| 06-16 | -88 | 0 | +4 | -88 |
| 06-15 | -5 | 0 | +2 | -4 |
| 06-12 | -40 | 0 | 0 | -41 |
| 06-11 | -7 | 0 | +10 | -6 |
| 06-10 | -38 | 0 | +10 | -38 |
| 06-09 | -51 | 0 | +4 | -51 |
| 06-08 | +45 | 0 | +8 | +45 |
| 06-05 | -5 | 0 | +12 | -79 |
| 06-04 | +35 | 0 | +2 | -41 |
| 06-03 | -71 | 0 | +2 | -71 |
| 06-02 | -143 | 0 | +34 | -143 |
| 06-01 | -70 | 0 | +8 | -69 |
| 05-29 | -87 | 0 | 0 | -87 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 3714 萬 | +2.8% | +3.4% |
| 2026/03 | 3611 萬 | -24.6% | -6.7% |
| 2026/02 | 4791 萬 | +58.3% | +32.3% |
| 2026/01 | 3027 萬 | -16.5% | +12.3% |
| 2025/12 | 3624 萬 | -13.0% | +49.6% |
| 2025/11 | 4167 萬 | +12.7% | +69.1% |
| 2025/10 | 3697 萬 | -2.1% | +29.8% |
| 2025/09 | 3776 萬 | +28.5% | +58.4% |
| 2025/08 | 2940 萬 | +16.9% | -53.6% |
| 2025/07 | 2514 萬 | -35.9% | +42.5% |
| 2025/06 | 3925 萬 | +11.4% | +77.6% |
| 2025/05 | 3522 萬 | - | +70.2% |